# What characterizes the exceptional cognition of superagers? A systematic review of multidomain biomarkers of successful cognitive aging

**Authors:** Yiru Yang, Xiaolei Li, Shudan Gao, Yuanxu Gao

PMC · DOI: 10.1093/geront/gnaf277 · The Gerontologist · 2025-11-24

## TL;DR

This review explores what makes some older adults maintain exceptional cognitive function by analyzing various biological markers linked to successful cognitive aging.

## Contribution

The study systematically categorizes and integrates multidomain biomarkers associated with successful cognitive aging for the first time.

## Key findings

- Successful cognitive aging is linked to multidomain biological mechanisms, not just resistance to aging-related brain changes.
- Key biomarkers include young DNA methylation age, high von Economo neuron density, and efficient glucose metabolism.
- Neuroimaging highlights a specific brain network involving the cingulate gyrus, medial temporal lobe, and frontal cortex.

## Abstract

Substantial heterogeneity in cognitive aging trajectories has been observed among older adults, with some individuals maintaining exceptional cognitive function (“superagers” or “successful cognitive aging [SCA]”). The biological mechanisms underlying SCA remain unclear. This systematic review synthesizes current evidence on quantifiable SCA biomarkers to address this critical gap.

Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we systematically searched PubMed, Scopus, PsycINFO, and Web of Science (up to December 2024). After screening 6,699 records, 62 studies met the inclusion criteria. Data from included studies were extracted, assessed for risk of bias, and synthesized for integrated findings.

We identified 34 SCA definitions, categorized them into three types, and analyzed biomarkers across six domains: (1) genetic/epigenetic biomarkers, (2) biofluid biomarkers, (3) histological biomarkers, (4) positron emission tomography biomarkers, (5) structural magnetic resonance imaging biomarkers, and (6) functional neuroimaging biomarkers. Integrated findings suggest that SCA is driven by unique multidomain biological mechanisms (e.g., young DNA methylation age, high von Economo neuron density, and efficient glucose metabolism, etc.), not merely resistance to age-related neuropathology such as amyloid-β and tau. Neuroimaging findings highlight the role of brain reserve, maintenance, and compensation on SCA, particularly within a newly defined “cingulate gyrus–medial temporal lobe–frontal cortex” brain signature.

This systematic review advances our understanding of SCA’s biological substrates, provides theoretical frameworks for future SCA biomarker research, and offers a foundation for future strategies to promote cognitive health in aging populations.

## Full-text entities

- **Genes:** MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}
- **Diseases:** neuropathology (MESH:D009422), Cognitive Aging (MESH:D003072), SCA (MESH:C565772)
- **Chemicals:** glucose (MESH:D005947)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13017228/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13017228/full.md

## References

87 references — full list in the complete paper: https://tomesphere.com/paper/PMC13017228/full.md

---
Source: https://tomesphere.com/paper/PMC13017228